Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/EVOKE PHARMA INC/ 15-12G

SEC Filing · 15-12G

EVOKE PHARMA INC

SEC Filing

Filed Dec 30, 2025Accepted Dec 30, 2025, 7:12 AM ESTCIK 1403708Accession 0001193125-25-336315
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
EVOKOTC · EQUITY · Historical · closed Dec 16, 2025

Recent company filings

  1. SCHEDULE 13D/A - filed by Nantahala Capital Management, LLC regarding Evoke Pharma IncDec 19, 2025
  2. EFFECT filingDec 18, 2025
  3. EFFECT filingDec 18, 2025
  4. EFFECT filingDec 18, 2025
  5. EFFECT filingDec 18, 2025

As-filed source

Primary evidence
As filedOpen full document ↗